GLYCOMIMETICS INC (GLYC) Stock News
NASDAQ:GLYC - Nasdaq - US38000Q1022 - Common Stock - Currency: USD
GLYC Latest News, Press Relases and Analysis
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CMRX and GLYC on Behalf of Shareholders
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
Mentions: CMRX
GLYC Stock Earnings: GlycoMimetics Misses EPS for Q1 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips GlycoMimetics (NASDAQ:GLYC) just reported results for the first quarter of 2024...
Top 5 Biotech Stocks That Got Most Retail Buzz Last Week
From merger updates to earnings surprises, these healthcare stocks saw the biggest spike in Stocktwits chatter.
GlycoMimetics Announces New Uproleselan Clinical Data Will Be Presented at ASH Annual Meeting
GLYC Stock Earnings: GlycoMimetics Misses EPS for Q1 2024
GLYC stock results show that GlycoMimetics missed analyst estimates for earnings per share the first quarter of 2024.
GLYCOMIMETICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of GlycoMimetics, Inc. - GLYC
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PFIE, CPTN, GLYC, ARC on Behalf of Shareholders
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PFIE and GLYC on Behalf of Shareholders
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
Mentions: PFIE
GLYC Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of GlycoMimetics, Inc. Is Fair to Shareholders
GlycoMimetics Enters Into Acquisition Agreement With Crescent Biopharma
GlycoMimetics Announces National Cancer Institute Phase 2/3 Study of Uproleselan Did Not Meet Primary Endpoint
GlycoMimetics Announces Strategic Review and Corporate Restructuring Plan
7 Sorry Biotech Stocks Set to Make Investors Sad
Biotech stocks can be extremely challenging because it takes a long time to bring a therapy to market. Here are some biotech stocks to sell.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
It's time to dive into the biggest pre-market stock movers as we check out all of the latest news happening on Wednesday morning!
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Pre-market stock movers are worth checking out on Tuesday as we get into all of the hottest news worth reading about this morning!
